{
  "zip": "V5X 4V6",
  "sector": "",
  "longBusinessSummary": "Med BioGene Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based clinical tests for cancer. The company focuses on the commercialization of technologies in various industrial sectors. Med BioGene Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.",
  "city": "Vancouver",
  "phone": "604 732 7332",
  "state": "BC",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.medbiogene.com",
  "maxAge": 1,
  "address1": "598 East Kent Avenue South",
  "fax": "604 732 4801",
  "industry": "",
  "previousClose": 0.035,
  "regularMarketOpen": 0.049632,
  "twoHundredDayAverage": 0.042517986,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.035,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.035,
  "fiftyDayAverage": 0.043636363,
  "trailingAnnualDividendRate": null,
  "open": 0.049632,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -0.615841,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.035,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 1100,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 869232,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 206,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.035,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 1100,
  "fiftyTwoWeekHigh": 0.06,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.01,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.035,
  "exchange": "PNK",
  "shortName": "MED BIOGENE INC",
  "longName": "Med BioGene Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "MBGNF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_22561488",
  "uuid": "7d2cf5e2-3d0d-30fc-b6b3-bd21b744f47e",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 8757840,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.006,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -45791,
  "trailingEps": -0.003,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.51413,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 6376622,
  "enterpriseValue": 463397,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1513641600,
  "lastSplitFactor": "1:10",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.049632,
  "logo_url": "https://logo.clearbit.com/medbiogene.com"
}